TrialHuman vaccines2010

An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection.

Atchriya Hemachandra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.